Iranian Journal of Diabetes and Obesity
Shahid Sadoughi University Of Medical Sciences
Thu, Apr 25, 2024
[Archive]
| Post date: 2024/01/16 |
Authorship and Acknowledgements:
Based on the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, by the ICMJE, Authors should have made significant conceptual, intellectual, experimental, and analytical contributions to the research, as well as having participated in writing and revising the manuscript. Also each author should have participated sufficiently in the work to be responsible for its content.
Each author should meet all criteria (A, B, C, and D) that recommended by the ICMJE as following conditions:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each author should be accountable for the parts of the work he or she has done. In addition, each author should be able to identify which coauthors are responsible for specific other parts of the work and should have confidence in the integrity of the contributions of any coauthors.
The authors also must certify that the manuscript represents valid data and has not been published in any form and is not being submitted for in the form of scientific presentations for publication elsewhere.
If requested, authors should be prepared to provide the data and must cooperate fully in obtaining and providing the data on which the manuscript is based for examination by the editors or their assignees.
The contributors who do not meet the authorship criteria should be mentioned as “Acknowledgments”.
Changes in Authorship: The authors should be agreed the order of authorship among themselves before submitting the manuscript. Changes in authorship (ie, order, addition, and deletion of authors) should be discussed and approved by all authors. Any requests for such changes in authorship after initial manuscript submission and before publication should be explained in a letter to the editor signed by all the authors or email from all authors.
Ethics of studies involving humans and animals
The research that involves human beings (or animals) must adhere to the principles of the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html).
All research participants should be informed about the aims of the study and any possible side effects of the drugs and intervention. Written informed consent under protocols approved by an institutional or local review board or approved animal protocols are essential if the research involves human or animal subjects, respectively. This information should be stated in the manuscript and the protocol number or exempt status of approved protocols should be stated in the manuscript at the time of submission for review.
Ethical considerations must be clearly addressed in the Materials and Methods section. Also the name of the appropriate institutional review board that approved the project should be mentioned.
The Journal reserves the right to request the related documents.
Clinical Trial Registration
According to the International Committee of Medical journal Editors (ICMJE) a Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.
Authors of clinical trials are required to prospectively register their trial with one of the ICMJE-recognized trial registries. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.
All of Iranian Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir), in order to be considered for publication. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O. such as:
- http://rctregistry.tums.ac.ir
-http://www.clicicaltrials.gov
- http://www.anzctr.org.au
- http://isrctn.org
- http:// www.trialregister.nl/trialreg/index.asp
- http://www.umin.ac.jp/ctr
Randomized control trials:
Randomized controlled trials must be according to The CONSORT Statement guideline.
Committee on Publication Ethics: IJDO is a member of the Committee on Publication Ethics (COPE).
Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged. Fraudulent data or data stolen from other authors is also unethical and will be treated accordingly. Any alleged offence is considered initially by the Editorial Team.
Retraction Policy: The IJDO for retraction of a published article uses the COPE flowchart (http://publicationethics.org/resources/guidelines)
International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/). The journal uses iThenticate plagiarism detection software to evaluate the originality of each manuscript. The journal reserves the right to report the allegations to the author’s institution or any other agency
Copyright Policy
Open Access (OA)
All articles published in IJDO are open access which means the articles are freely available online for anyone to download and use the providing address to the individual authors. In IJDO as an open access journal, authors sign a publishing agreement where they will have copyright but grant broad publishing and distribution rights to the publisher, including the right to publish the article on IJDO's website and choose the end-user license under which readers can use and share the articles. Then IJDO provides the article's online access for using and sharing by readers. Permitted (re) use is defined by Creative Commons Attribution (CC BY 4.0).
Creative Commons Attribution (CC BY 4.0): permit users to copy, to create extracts abstracts, abstracts and new works from the article, to alter and revise the article, and to make commercial use of the article
Copyright Form
Conflicts of interest
All authors must inform us about any kinds of financial, personal, political, or academic "Conflict of Interest that would potentially affect their judgment. Authors are preferably asked to fill the uniform disclosure form available through: (http://www.icmje.org/coi_disclosure.pdf)
Notice
Ethics committee approval code is necessary for all type of manuscripts.
Based on the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, by the ICMJE, Authors should have made significant conceptual, intellectual, experimental, and analytical contributions to the research, as well as having participated in writing and revising the manuscript. Also each author should have participated sufficiently in the work to be responsible for its content.
Each author should meet all criteria (A, B, C, and D) that recommended by the ICMJE as following conditions:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each author should be accountable for the parts of the work he or she has done. In addition, each author should be able to identify which coauthors are responsible for specific other parts of the work and should have confidence in the integrity of the contributions of any coauthors.
The authors also must certify that the manuscript represents valid data and has not been published in any form and is not being submitted for in the form of scientific presentations for publication elsewhere.
If requested, authors should be prepared to provide the data and must cooperate fully in obtaining and providing the data on which the manuscript is based for examination by the editors or their assignees.
The contributors who do not meet the authorship criteria should be mentioned as “Acknowledgments”.
Changes in Authorship: The authors should be agreed the order of authorship among themselves before submitting the manuscript. Changes in authorship (ie, order, addition, and deletion of authors) should be discussed and approved by all authors. Any requests for such changes in authorship after initial manuscript submission and before publication should be explained in a letter to the editor signed by all the authors or email from all authors.
Ethics of studies involving humans and animals
The research that involves human beings (or animals) must adhere to the principles of the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html).
All research participants should be informed about the aims of the study and any possible side effects of the drugs and intervention. Written informed consent under protocols approved by an institutional or local review board or approved animal protocols are essential if the research involves human or animal subjects, respectively. This information should be stated in the manuscript and the protocol number or exempt status of approved protocols should be stated in the manuscript at the time of submission for review.
Ethical considerations must be clearly addressed in the Materials and Methods section. Also the name of the appropriate institutional review board that approved the project should be mentioned.
The Journal reserves the right to request the related documents.
Clinical Trial Registration
According to the International Committee of Medical journal Editors (ICMJE) a Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.
Authors of clinical trials are required to prospectively register their trial with one of the ICMJE-recognized trial registries. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.
All of Iranian Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir), in order to be considered for publication. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O. such as:
- http://rctregistry.tums.ac.ir
-http://www.clicicaltrials.gov
- http://www.anzctr.org.au
- http://isrctn.org
- http:// www.trialregister.nl/trialreg/index.asp
- http://www.umin.ac.jp/ctr
Randomized control trials:
Randomized controlled trials must be according to The CONSORT Statement guideline.
Committee on Publication Ethics: IJDO is a member of the Committee on Publication Ethics (COPE).
Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged. Fraudulent data or data stolen from other authors is also unethical and will be treated accordingly. Any alleged offence is considered initially by the Editorial Team.
Retraction Policy: The IJDO for retraction of a published article uses the COPE flowchart (http://publicationethics.org/resources/guidelines)
International Committee of Medical Journal Editors, ICMJE (http://www.icmje.org/). The journal uses iThenticate plagiarism detection software to evaluate the originality of each manuscript. The journal reserves the right to report the allegations to the author’s institution or any other agency
Copyright Policy
Open Access (OA)
All articles published in IJDO are open access which means the articles are freely available online for anyone to download and use the providing address to the individual authors. In IJDO as an open access journal, authors sign a publishing agreement where they will have copyright but grant broad publishing and distribution rights to the publisher, including the right to publish the article on IJDO's website and choose the end-user license under which readers can use and share the articles. Then IJDO provides the article's online access for using and sharing by readers. Permitted (re) use is defined by Creative Commons Attribution (CC BY 4.0).
Creative Commons Attribution (CC BY 4.0): permit users to copy, to create extracts abstracts, abstracts and new works from the article, to alter and revise the article, and to make commercial use of the article
Copyright Form
Conflicts of interest
All authors must inform us about any kinds of financial, personal, political, or academic "Conflict of Interest that would potentially affect their judgment. Authors are preferably asked to fill the uniform disclosure form available through: (http://www.icmje.org/coi_disclosure.pdf)
Notice
Ethics committee approval code is necessary for all type of manuscripts.
View: 2531 Time(s) |
Print: 406 Time(s) |
Email: 0 Time(s) |
0 Comment(s)
